VETFLURANE 1000 MG/G INHALATION VAPOUR, LIQUID

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

ISOFLURANE

Available from:

Virbac S.A.

ATC code:

QN01AB06

INN (International Name):

ISOFLURANE

Dosage:

1000 mg/g

Pharmaceutical form:

Inhalation Vapour Liquid

Prescription type:

VPO-Vet.Practitioner Only

Therapeutic group:

Avian, Canine, Equine - Food, Feline, Ferret, Gerbils, Guinea Pigs, Hamsters, Non Food Animals, Reptile

Therapeutic area:

Isoflurane

Therapeutic indications:

Neurological Preparations

Authorization status:

Authorised

Authorization date:

2010-09-24

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Vetflurane 1000 mg/g Inhalation vapour, liquid
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each millilitre contains:
Active substance:
Isoflurane 1000 mg/g.
The veterinary medicinal product contains no excipients.
3 PHARMACEUTICAL FORM
Inhalation vapour, liquid.
Clear, colourless liquid.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters, chinchillas, gerbils, guinea pigs and ferrets.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Induction and maintenance of general anaesthesia.
4.3 CONTRAINDICATIONS
Do not use in case of known susceptibility to malignant hyperthermia.
Do not use in cases of known hypersensitivity to isoflurane or to other halogenated agents.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The metabolism of birds, and to an extent small mammals, is affected more profoundly by decreases in body
temperature, due to high surface area to body weight ratio. Drug metabolism in reptiles is slow and highly dependent
upon environmental temperature.
The absorption, distribution and elimination of isoflurane are rapid, and it is eliminated largely unchanged via the
lungs. These characteristics may make it suitable for groups of patients including the young or old, or those with
impaired hepatic, renal or cardiac function, however anaesthetic protocols should be decided on a case by case basis.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 19/02/2016_
_CRN 7019457_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Isoflurane has little or no analgesic properties. Adequate analgesia should always be given